NTRK3 and cancer: Results provide evidence that SLITRK3 gene amplification frequently occurring in LUSC causes aberrant SLITRK3 overexpression and facilitates SLITRK3-dependent ligand activation of NTRK3 to induce a cancer stem cell (CSC) phenotype.